CENCORA INC

Insider buying of Cencora shares signals board confidence and a potential rebound for the healthcare provider, offering investors a bullish outlook.

Insider buying by Tyler Lauren M shows steady confidence in Cencora’s growth, suggesting potential upside for long‑term investors.

Insider buying by Cencora’s Durcan Dermot Mark signals confidence amid volatility, boosting investor confidence in its federal contracts and earnings potential.

Insider buying at Cencora shows confidence, not panic—Durcan Dermot Mark’s 4,000‑share purchase signals long‑term conviction and potential upside.

CEO Robert Mauch sells 1,333 shares of Cencora stock a day after the $3.5 B Covetrus merger, indicating routine liquidity management amid a promising veterinary tech expansion.

Insider buying by Cencora’s executive Silvana signals confidence in the firm’s rebound, amid high P/E, positive sentiment and a near‑peak stock price.